Table 5.
Expected and observed deaths according to cancer type
| Cancer type | Autologous | Allogeneic | ||||||
|---|---|---|---|---|---|---|---|---|
| Expected* | Observed | SMR (95% CI) | P | Expected* | Observed | SMR (95% CI) | P | |
| All | 47.0 | 84 | 1.79 (1.43-2.21) | <.001 | 107.6 | 179 | 1.66 (1.43-1.93) | <.001 |
| Oral cavity/pharynx | 2.3 | 2 | 0.87 (0.11-3.14) | 1.0 | 24.7 | 31 | 1.26 (0.85-1.78) | .25 |
| Esophagus | 1.8 | 2 | 1.11 (0.13-4.01) | 1.0 | 38.8 | 40 | 1.03 (0.74-1.40) | .89 |
| Stomach | 3.6 | 8 | 2.22 (0.96-4.38) | .16 | 5.7 | 8 | 1.40 (0.61-2.77) | .43 |
| Colon | 5.9 | 13 | 2.20 (1.17-3.77) | .02 | 8.5 | 18 | 2.12 (1.26-3.35) | .007 |
| Liver | 7.1 | 8 | 1.13 (0.49-2.22) | .83 | 3.4 | 3 | 0.88 (0.18-2.58) | 1.0 |
| Pancreas | 5.0 | 5 | 1.00 (0.32-2.33) | 1.0 | 9.8 | 10 | 1.02 (0.49-1.88) | 1.0 |
| Lung | 18.7 | 17 | 0.91 (0.53-1.46) | .81 | 18.8 | 21 | 1.12 (0.69-1.71) | .67 |
| Bone/soft tissue | 1.9 | 6 | 3.16 (1.16-6.87) | .03 | 3.7 | 11 | 2.97 (1.48-5.32) | .003 |
| Skin | NA | 0 | NA | NA | 2.7 | 5 | 1.85 (0.60-4.32) | .27 |
| Breast | 1.0 | 5 | 5.00 (1.62-11.7) | .01 | 1.5 | 1 | 0.67 (0.02-3.71) | 1.0 |
| Cervix uteri | NA | 1 | NA | NA | 0.7 | 2 | 2.86 (0.35-10.3) | .31 |
| Corpus uteri | NA | 3 | NA | NA | 0.6 | 1 | 1.67 (0.04-9.29) | 1.0 |
| Prostate | 0.6 | 0 | NA | NA | 0.6 | 2 | 3.33 (0.40-12.0) | .24 |
| Kidney | 1.5 | 1 | 0.67 (0.02-3.71) | 1.0 | 0.5 | 1 | 2.00 (0.05-11.1) | .79 |
| Bladder | 1.2 | 1 | 0.83 (0.02-4.64) | 1.0 | 1.2 | 2 | 1.67 (0.20-6.02) | .68 |
| Central nervous system | NA | 1 | NA | NA | 7.1 | 10 | 1.41 (0.68-2.59) | .35 |
| Thyroid | 0.2 | 1 | 5.00 (0.13-27.9) | .36 | 0.4 | 1 | 2.50 (0.06-13.9) | .66 |
*
Expected number of deaths in the age- and sex-matched general population of primary cancer.